[PDF] Top 20 The role of arachidonic acid mobilisation in myeloid cells

... Neutrophils play a crucial role in host protection against microbial infection. N eutrophils are activated in response to a variety of stim uli, including chemoattractants, cytokines and immune complexes (Metcalf, ... See full document

... of myeloid cells with distinctly different ...these cells from the progenitor cell ...these cells and their function within the immune system is likely to open opportunities for new ... See full document

... MIN6 cells, the HO342 fluorescence was homogenously distributed throughout the cell nuclei and no chromatin condensation or nuclear fragmentation was evident ...control cells studied. In contrast, the ... See full document

... The role of acute or chronic systemic inflammation in the AD progression emerged quite recently in literature and was initially focused on the circulation of pro-inflammatory cytokines (Holmes et ...critical ... See full document

... blood cells is greatly reduced by similar lipoxygenase inhibitors (Thoroed and Fugelli, ...a role for arachidonic acid metabolites as signals for volume recovery following cell swelling in ... See full document

... donic acid (AA) is one of the most abundant polyunsaturated fatty acids in verte- brates and is released in large amounts during the oxidative ...its role in inflammatory signaling, AA is toxic to ... See full document

... a role in the anchorage of these cells to host cells during ...fatty acid production may be an important virulence factor in ...mammalian cells by affecting signal transduction ... See full document

... damaged cells and ...from arachidonic acid can occur via several pathways, including the prostaglandin H synthase (PHS) pathway, the cyclooxygenase (COX) pathway, and the lipoxygenase (LOX) ...from ... See full document

... liver cells for their effect on arachidonic acid (AA) release and prostaglandin I 2 production induced in the presence of lactacystin and ...a role in some of the pharmacological effects ... See full document

... of arachidonic acid in the brain ...the role of astrocytes might be ...of arachidonic acid could also be one of the factors that causes neuronal death in Parkinson’s ...endogenous ... See full document

... hippocampal cells (rather than in slice) for two ...pyramidal cells are covered by layers of debris and glia which make obtaining a good seal very difficult; this is not the case in ...the cells ... See full document

... monooxygenase pathway, or by pretreating the animals with CoCl2, which depletes cytochrome P450. Equimolar concentrations (10(-7) M) of the cyclooxygenase inhibitors indomethacin or meclofenamate caused only a partial ... See full document

... endothelial cells (Sordillo et ...PHGPx-deficient cells undergo a form of apoptosis were obtained from time-lapse videos, showing stereotypical morphological changes, such as shrinking, deformation, loss of ... See full document

... Evaluation of the products of the lipoxygenase and cyclooxygenase pathway in the platelet of the neonate revealed an increase in the production of the lipoxygenase product HETE, whereas [r] ... See full document

... mature myeloid or lymphoid cells, and the decrease in MDSCs was asso- ciated with progression-free survival ...dendritic cells and ...retinoic acid signaling using all-trans retinoid ... See full document

... pathogenesis of atherosclerosis and aging, and may account in part for reduced vascular prostacyclin (PGI2) synthesis associated with both conditions. Using H2O2 to induce injury, we investigated the effects of oxidative ... See full document

... bromophenacyl bromide (10(-5) M). Calcium ionophore A23187 (10(-5) M) further increased the [3H]AA release from the IFN-gamma-treated cells. Subcellular enzyme activity assay revealed that IFN-gamma increased PLA2 ... See full document

... the role of arachidonic acid (ARA, C20:4 ω-6) was less extensively studied, despite the fact that it is the second PUFA in the brain. ARA corresponds to around 20% of the total amount of the neuronal ... See full document

... Abstract: Dasatinib is a second-generation tyrosine kinase inhibitor (TKI) for chronic, blastic, or accelerated phase chronic myeloid leukemia (CML) patients who are resistant or intolerant to previous treatment. ... See full document

... arachidonic acid oxygenase. The inhibition of PGE biosynthesis resulted in augmented vasopressin- and theophylline-stimulated water flow, but had no effect on cyclic AMP- stimulated water flow. We interpret ... See full document